Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA clears SSRI for depression

July 22, 1998

Preclinical results point to anxiolytic efficacy for Yoshitomi benzodiazepine

July 22, 1998

Analgesic effects of dosulepin in patients with cancer-related pain

July 22, 1998

Icos begins phase II multiple-dose trial in multiple sclerosis patients

July 22, 1998

Spotlight on sigma-receptors as a target for intervention in CNS disorders

July 22, 1998

Benzodiazepine omega3 receptor ligands with anxiolytic, anticonvulsant and antiarthritic effects

July 22, 1998

New indication explored for established anticonvulsant

July 21, 1998

EEG analysis reveals the atypical antipsychotic profile of OPC-14597

July 21, 1998

SIB-1553A goes head-to-head with established cognition-enhancing drugs

July 21, 1998

Hypnotic effects of the benzodiazepine receptor ligand SX-3228 in rats

July 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...